Dianthus Therapeutics, Inc. Common Stock (DNTH) Financials
Key financial figures for Dianthus Therapeutics, Inc. Common Stock (Q1 2026).
- Revenue
- $463K
- Net Income
- -$41M
- EPS
- $-0.85
- Total Assets
- $1.2B
- Operating Cash Flow
- -$29M
Full income statement, balance sheet, and cash flow for Dianthus Therapeutics, Inc. Common Stock on SentiSense.